WallStreetZenWallStreetZen

NASDAQ: ORIC
Oric Pharmaceuticals Inc Stock Ownership - Who owns Oric Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oric Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dominic PiscitelliChief Financial Officer2025-07-0120,000$10.05
$200.98kSell
Dominic PiscitelliChief Financial Officer2025-06-2432,466$10.51
$341.06kSell
Angie YouDirector2025-06-231,403$9.43
$13.23kBuy
Dominic PiscitelliChief Financial Officer2025-06-23450$10.01
$4.50kSell
Dominic PiscitelliChief Financial Officer2025-06-23584$10.00
$5.84kSell
Angie YouDirector2025-06-2026,597$9.39
$249.67kBuy
Dominic PiscitelliChief Financial Officer2025-06-12300$10.00
$3.00kSell
Dominic PiscitelliChief Financial Officer2025-06-111,276$10.00
$12.76kSell
Dominic PiscitelliChief Financial Officer2025-06-111,700$10.01
$17.02kSell
Dominic PiscitelliChief Financial Officer2025-06-10324$10.00
$3.24kSell

1 of 2

ORIC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORIC insiders and whales buy or sell their stock.

ORIC Shareholders

What type of owners hold Oric Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pfizer Inc5.54%5,376,344$52.85MInstitution
Pfizer Inc5.54%5,376,344$52.85MInsider
Peter Svennilson4.91%4,768,181$46.87MInsider
Blackrock Inc4.20%4,077,985$40.09MInstitution
Column Group II LP3.67%3,568,255$35.08MInsider
Vanguard Group Inc3.22%3,124,693$30.72MInstitution
Orbimed Advisors LLC2.28%2,212,571$21.75MInsider
Carl L. Gordon2.28%2,212,571$21.75MInsider
Topspin Fund LP2.21%2,144,320$21.08MInsider
Jpmorgan Chase Co1.38%1,335,448$13.13MInstitution

1 of 3

ORIC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORIC20.89%22.16%Net SellingNet Selling
STOK25.81%74.19%Net SellingNet Selling
OCS7.73%0.00%
NUVB29.88%46.87%Net BuyingNet Buying
MLYS43.56%56.44%Net BuyingNet Selling
View Top Biotech Stocks

Oric Pharmaceuticals Stock Ownership FAQ

Who owns Oric Pharmaceuticals?

Oric Pharmaceuticals (NASDAQ: ORIC) is owned by 20.89% institutional shareholders, 22.16% Oric Pharmaceuticals insiders, and 56.95% retail investors. Pfizer Inc is the largest individual Oric Pharmaceuticals shareholder, owning 5.38M shares representing 5.54% of the company. Pfizer Inc's Oric Pharmaceuticals shares are currently valued at $53.39M.

If you're new to stock investing, here's how to buy Oric Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.